PT Industri Jamu Dan Farmasi Sido Muncul Tbk is an Indonesia-based company, which carries out business activities in herbal industry, such as medical industry (pharmacy), herbs, cosmetics, foods and beverages related to health, commerce, land transportation, services, wastewater treatment, plantation, and printing. The Company's segments include Herbal medicine and supplement, Food and beverages, and Pharmacy. The Companyâs products include Tolak Angin Cair, Tolak Angin Anak + Madu, Tolak Angin Flu, Tolak Angin Sugar Free, Sido Muncul Tolak Linu, Kuku Bima Ener-G!, Susu Jahe, Kopi Jahe, Sido Muncul C-1000 (Dengan Ekstrak Lemon), Esemag, Sari Kunyit Soft Capsule, Tolak Angin Soft Capsule, Tolak Linu Soft Capsule, JSH Capsule, VCO Soft Capsule, Sido Muncul Vitamin D3 400 IU, Sido Muncul VItamin E 100 IU, Sido Muncul Vitamin E 300 IU, Minuman Madu dengan Jahe maduSido, Tolak Angin Care, Tolak Linu Cool, Anak Sehat Rasa Anggur, Anak Sehat Rasa Coklat, and Anak Sehat Rasa Jambu Merah.

Employees

3,602

Sector

Pharmaceuticals

Calendar

Jul. 28 - Q2 2025 Earnings Release (Projected)

More about the company

Quotes

Date	Price	Change	Volume
25-06-23	484.00 Rp	-1.22%	29,428,000
25-06-20	490.00 Rp	-0.41%	38,961,700
25-06-19	492.00 Rp	-1.60%	39,593,900
25-06-18	500.00 Rp	0.00%	24,188,300
25-06-17	500.00 Rp	0.00%	24,027,200

End-of-day quote INDONESIA S.E., June 22, 2025

More quotes

Income Statement and Estimates

More financial data

Ratings

Trading Rating

Investor Rating

ESG MSCI

BBB

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

12

Last Close Price

484.00IDR

Average target price

596.25IDR

Spread / Average Target

+23.19%

Consensus

EPS Estimates

Revisions to estimates

Quarterly revenue - Rate of surprise

Company calendar

End-of-day quote INDONESIA S.E. Other stock markets 2025-06-23			5-day change	1st Jan Change
484.00 ^IDR	-1.22%		-3.20%	-17.97%

Jun. 20	PT Industri Jamu dan Farmasi Sido Muncul Tbk's Equity Buyback Plan Extended till September 22, 2025.	CI
May. 02	PT Industri Jamu dan Farmasi Sido Muncul Tbk Reports Earnings Results for the First Quarter Ended March 31, 2025	CI

Capitalization	14,513B 880M 763M 715M 652M 1.21B 76.22B 1.37B 8.48B 3.26B 34.97B 3.3B 3.23B 129B	P/E ratio 2025 *	13x	P/E ratio 2026 *	11.2x
Enterprise value	13.64B 827K 717K 672K 613K 1.14M 71.62M 1.28M 7.97M 3.06M 32.86M 3.1M 3.04M 121M	EV / Sales 2025 *	3.44x	EV / Sales 2026 *	3.05x
Free-Float	22.39%	Yield 2025 *	7.19%	Yield 2026 *	7.82%

PT Industri Jamu dan Farmasi Sido Muncul Tbk's Equity Buyback Plan Extended till September 22, 2025.	Jun. 20	CI
PT Industri Jamu dan Farmasi Sido Muncul Tbk Reports Earnings Results for the First Quarter Ended March 31, 2025	May. 02	CI
HSBC Upgrades Industri Jamu Dan Farmasi Sido Muncul to Buy from Hold; Price Target is 675 Rupiah	Mar. 19	MT
PT Industri Jamu dan Farmasi Sido Muncul Tbk announces an Equity Buyback for 450,000,000 shares, representing 1.5% for IDR 300,000 million.	Mar. 17	CI
PT Industri Jamu dan Farmasi Sido Muncul Tbkauthorizes a Buyback Plan.	Mar. 16	CI
PT Industri Jamu dan Farmasi Sido Muncul Tbk Reports Earnings Results for the Full Year Ended December 31, 2024	Mar. 06	CI
Nomura Adjusts Industri Jamu Dan Farmasi Sido Muncul's Price Target to 700 Rupiah From 800 Rupiah, Keeps at Buy	Jan. 28	MT
PT Industri Jamu dan Farmasi Sido Muncul Tbk Reports Earnings Results for the Nine Months Ended September 30, 2024	24-10-24	CI
PT Industri Jamu dan Farmasi Sido Muncul Tbk Reports Earnings Results for the Half Year Ended June 30, 2024	24-07-24	CI
PT Industri Jamu dan Farmasi Sido Muncul Tbk Reports Earnings Results for the First Quarter Ended March 31, 2024	24-04-25	CI
Nomura Adjusts Industri Jamu Dan Farmasi’s Price Target to IDR800 From IDR670, Keeps at Buy	24-04-18	MT
Hidayat family acquired 17.1% stake in PT Industri Jamu dan Farmasi Sido Muncul Tbk from Affinity Equity Partners Limited for approximately $200 million.	24-04-15	CI
Nomura Adjusts Industri Jamu Dan Farmasi Sido Muncul's Price Target to IDR670 From IDR750, Keeps at Buy	24-02-20	MT

HSBC Upgrades Industri Jamu Dan Farmasi Sido Muncul to Buy from Hold; Price Target is 675 Rupiah	Mar. 19	MT
Nomura Adjusts Industri Jamu Dan Farmasi Sido Muncul's Price Target to 700 Rupiah From 800 Rupiah, Keeps at Buy	Jan. 28	MT
Nomura Adjusts Industri Jamu Dan Farmasi’s Price Target to IDR800 From IDR670, Keeps at Buy	24-04-18	MT
Nomura Adjusts Industri Jamu Dan Farmasi Sido Muncul's Price Target to IDR670 From IDR750, Keeps at Buy	24-02-20	MT
Nomura Adjusts Industri Jamu Dan Farmasi Sido Muncul’s Price Target to 750 Rupiahs From 870 Rupiahs, Keeps at Buy	23-10-10	MT

PT Industri Jamu dan Farmasi Sido Muncul Tbk Stock

Equities

SIDO

ID1000130305

Pharmaceuticals

Valuation: PT Industri Jamu dan Farmasi Sido Muncul Tbk

Chart: PT Industri Jamu dan Farmasi Sido Muncul Tbk

Latest news: PT Industri Jamu dan Farmasi Sido Muncul Tbk

Analysts' recommendations: PT Industri Jamu dan Farmasi Sido Muncul Tbk

Quotes and Performance

Course Extremes

Managers and Directors: PT Industri Jamu dan Farmasi Sido Muncul Tbk

ETFs: PT Industri Jamu dan Farmasi Sido Muncul Tbk

Alternative Medicine

Financials

Company Profile

Quotes

Income Statement and Estimates

Ratings

Analysts' Consensus

Quarterly revenue - Rate of surprise

1 day	-1.22%
1 week	-3.20%
Current month	-6.02%
1 month	-9.53%
3 months	-13.57%
6 months	-15.09%
Current year	-17.97%

Manager	Title	Age	Since
David Hidayat CEO	Chief Executive Officer	69	1997-12-31
Budiyanto DFI	Director of Finance/CFO	49	2024-05-14
Irwan Hidayat CEO	Chief Executive Officer	78	2013-04-30

Director	Title	Age	Since
Sigit Hartojo Hadi Santoso CHM	Chairman	76	2013-04-30
Johan Hidajat BRD	Director/Board Member	75	1971-12-31
Jonatha Sofjan Hidajat CHM	Chairman	77	2018-05-29

Name	Weight	AuM	1st Jan change
DEMOCRACY INTERNATIONAL FUND ETF - USD	0%	9 M€	+12.85%	-
MYETF MSCI SEA ISLAMIC DIVIDEND ETF - MYR	0%	9 M€	-3.62%	-

	2025 *	2026 *
Net sales	3,960B 240M 208M 195M 178M 330M 20.8B 373M 2.31B 890M 9.54B 901M 882M 35.15B	4,405B 267M 231M 217M 198M 367M 23.13B 415M 2.57B 990M 10.61B 1B 981M 39.1B
Net income	1,102B 66.85M 57.92M 54.32M 49.52M 91.79M 5.79B 104M 644M 248M 2.66B 251M 246M 9.79B	1,308B 79.33M 68.73M 64.46M 58.76M 109M 6.87B 123M 764M 294M 3.15B 298M 291M 11.61B
Net Debt	-875B -53.07M -45.98M -43.12M -39.31M -72.87M -4.6B -82.44M -511M -197M -2.11B -199M -195M -7.77B	-1,071B -64.93M -56.26M -52.76M -48.09M -89.15M -5.62B -101M -625M -241M -2.58B -244M -238M -9.5B

1 week	480	510
1 month	480	540
Current year	480	630
1 year	480	780
3 years	478	1,010
5 years	478	1,070
10 years	208.41	1,070

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi.($)
PT INDUSTRI JAMU DAN FARMASI SIDO MUNCUL TBK	-1.22%	-3.20%	-34.59%	-50.86%	880M
DONG-E-E-JIAO CO.,LTD.	-0.65%	-1.87%	-21.48%	+43.99%	4.65B
HUBEI JUMPCAN PHARMACEUTICAL CO., LTD.	+0.07%	-1.12%	-15.54%	-3.86%	3.52B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	+0.07%	-3.27%	-13.75%	-45.18%	3.24B
TASLY PHARMACEUTICAL GROUP CO., LTD	-0.13%	-2.09%	+17.63%	+47.71%	3.22B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	-0.15%	-2.42%	-4.57%	+32.56%	3.1B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	+0.13%	-2.80%	+2.11%	-18.99%	2.35B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	-1.71%	-5.28%	-7.74%	+76.67%	1.76B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.	-0.67%	-4.67%	+13.12%	-14.72%	1.64B
ZHEJIANG JOLLY PHARMACEUTICAL CO.,LTD	-0.06%	-2.84%	+8.40%	+66.30%	1.62B
Average	-0.43%	-2.01%	-5.64%	+13.36%	2.6B
Weighted average by Cap.	-0.32%	-1.77%	-6.17%	+16.47%